Rep. Jared Moskowitz Sells West Pharmaceutical Services, Inc. (NYSE:WST) Stock

Representative Jared Moskowitz (D-Florida) recently sold shares of West Pharmaceutical Services, Inc. (NYSE:WST). In a filing disclosed on December 09th, the Representative disclosed that they had sold between $1,001 and $15,000 in West Pharmaceutical Services stock on November 8th. The trade occurred in the Representative’s “MORGAN STANLEY ACTIVE ASSETS (1)” account.

Representative Jared Moskowitz also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Atmos Energy (NYSE:ATO) on 11/8/2024.
• Purchased $1,001 – $15,000 in shares of Elevance Health (NYSE:ELV) on 11/8/2024.
• Purchased $1,001 – $15,000 in shares of Amazon.com (NASDAQ:AMZN) on 11/8/2024.
• Purchased $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 11/8/2024.
• Purchased $1,001 – $15,000 in shares of QUALCOMM (NASDAQ:QCOM) on 11/8/2024.
• Purchased $1,001 – $15,000 in shares of PepsiCo (NASDAQ:PEP) on 11/8/2024.
• Purchased $1,001 – $15,000 in shares of Tractor Supply (NASDAQ:TSCO) on 11/8/2024.
• Purchased $1,001 – $15,000 in shares of McDonald’s (NYSE:MCD) on 11/8/2024.
• Purchased $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOG) on 11/8/2024.
• Sold $50,001 – $100,000 in shares of Seacoast Banking Co. of Florida (NASDAQ:SBCF) on 11/8/2024.

West Pharmaceutical Services Stock Performance

West Pharmaceutical Services stock opened at $322.16 on Tuesday. West Pharmaceutical Services, Inc. has a fifty-two week low of $265.00 and a fifty-two week high of $413.70. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.23 and a current ratio of 3.00. The stock has a market cap of $23.33 billion, a P/E ratio of 47.80, a price-to-earnings-growth ratio of 24.47 and a beta of 1.01. The firm’s fifty day moving average price is $310.61 and its 200-day moving average price is $311.75.

West Pharmaceutical Services (NYSE:WST) last released its quarterly earnings results on Thursday, October 24th. The medical instruments supplier reported $1.85 earnings per share for the quarter, beating analysts’ consensus estimates of $1.50 by $0.35. West Pharmaceutical Services had a return on equity of 18.41% and a net margin of 17.37%. The business had revenue of $746.90 million for the quarter, compared to the consensus estimate of $709.62 million. During the same quarter last year, the business posted $2.16 earnings per share. The company’s revenue for the quarter was down .1% on a year-over-year basis. On average, equities research analysts expect that West Pharmaceutical Services, Inc. will post 6.64 earnings per share for the current fiscal year.

West Pharmaceutical Services Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, November 20th. Stockholders of record on Wednesday, November 13th were issued a $0.21 dividend. This is a positive change from West Pharmaceutical Services’s previous quarterly dividend of $0.20. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.26%. West Pharmaceutical Services’s dividend payout ratio is presently 12.46%.

Insider Activity

In other West Pharmaceutical Services news, VP Charles Witherspoon sold 703 shares of the business’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $310.40, for a total value of $218,211.20. Following the transaction, the vice president now owns 1,253 shares in the company, valued at approximately $388,931.20. The trade was a 35.94 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.53% of the company’s stock.

Institutional Trading of West Pharmaceutical Services

A number of hedge funds have recently bought and sold shares of the company. Crewe Advisors LLC boosted its position in West Pharmaceutical Services by 322.7% during the second quarter. Crewe Advisors LLC now owns 93 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 71 shares during the period. Northwest Investment Counselors LLC bought a new stake in shares of West Pharmaceutical Services in the 3rd quarter valued at about $30,000. Brooklyn Investment Group purchased a new stake in West Pharmaceutical Services during the 3rd quarter valued at about $41,000. Quest Partners LLC grew its position in West Pharmaceutical Services by 5,633.3% during the 2nd quarter. Quest Partners LLC now owns 172 shares of the medical instruments supplier’s stock worth $57,000 after acquiring an additional 169 shares during the last quarter. Finally, Blue Trust Inc. increased its stake in West Pharmaceutical Services by 332.1% in the 2nd quarter. Blue Trust Inc. now owns 242 shares of the medical instruments supplier’s stock worth $80,000 after purchasing an additional 186 shares during the period. Institutional investors own 93.90% of the company’s stock.

About Representative Moskowitz

Jared Evan Moskowitz (Democratic Party) is a member of the U.S. House, representing Florida’s 23rd Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2025. Moskowitz (Democratic Party) is running for re-election to the U.S. House to represent Florida’s 23rd Congressional District. He declared candidacy for the Democratic primary scheduled on August 20, 2024. Moskowitz resigned his state House seat on January 11, 2019, to head the state’s Division of Emergency Management. Jared Evan Moskowitz was born in Coral Springs, Florida. Moskowitz graduated from Marjory Stoneman Douglas High School. He earned a bachelor’s degree in political science and government from George Washington University in 2003 and a law degree from Nova Southeastern University in 2007. Moskowitz’s career experience includes working as the director of the Florida Division of Emergency Management and general counsel with AshBritt Inc.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.